PS01.55: IMpower010: Phase III Study of Atezolizumab vs BSC After Adjuvant Chemotherapy in Patients with Completely Resected NSCLC: Topic: Medical Oncology.

Eric Vallieres, Enriqueta Felip, Nasser Altorki, Caicun Zhou, Yunxia Zuo, Michael Howland, Fan Xia, Tien Hoang, Alan Sandler, Heather Wakelee Swedish Cancer Institute, Seattle, WA/United States of America, Vall d’Hebron University Hospital, Barcelona/Spain, New YorkePresbyterian Hospital, Weill Cornell Medicine, New York, NY/United States of America, Tongji… CONTINUE READING